walleyjohnson992@gmail.com - GST NO. : 29AYRPS8099J3ZZ
- Send Email
| Business Type | Supplier, Trader |
| Brand Name | Nitib |
| Form | Capsules |
| Strength | 140 Mg |
| Click to view more | |
Product Details
Country of Origin
India
Type
Pharmaceutical
Usage/Application
Clinical, Hospital
Nitib is indicated for Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma, Waldenstrom’s Macroglobulinemia, Marginal zone Lymphoma, Chronic Graft Versus Host Disease. Ibrutinib is a first line treatment in those with CLL who require treatment and are newly diagnosed. It may also be used in CLL that relapses.
Looking for "Ibrutinib Capsuls140 Mg" ?
Box
